Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: Slentrol
Auth. number : EU/2/07/071
Active substance : Dirlotapide
ATC: Anatomical main group: QA - Alimentary tract and metabolism
Therapeutic subgroup: QA08 - Antiobesity preparations, excl. diet products
Pharmacological subgroup: QA08A - Antiobesity preparations, excl. diet products
Chemical subgroup: QA08AB - Peripherally acting antiobesity products
Chemical substance: QA08AB91 - dirlotapide
(See WHO ATCvet Index)
Indication: As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight management programme which also includes appropriate dietary changes and exercise practice
Marketing Authorisation Holder: Zoetis Belgium S.A.
rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/04/2007 Centralised - Authorisation EMEA/V/C/116 (2007)1734 of 13/04/2007
11/01/2010 Centralised - Variation EMEA/V/C/116/IB/1
Updated with Decision(2010)2411 of 09/04/2010
13/04/2010 Centralised - Variation (2010)2411 of 09/04/2010
10/12/2010 Centralised - Variation EMEA/V/C/116/IB/2
Updated with Decision(2011)5609 of 27/07/2011
02/08/2011 Centralised - Variation (2011)5609 of 27/07/2011
12/04/2012 Centralised - Renewal EMEA/V/C/116/R/3 (2012)2454 of 10/04/2012
11/01/2013 Centralised - Variation EMEA/V/C/116/IB/5
Updated with Decision(2013)3225 of 27/05/2013
29/05/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/116/T/6 (2013)3225 of 27/05/2013
05/09/2013 Centralised - Variation EMEA/V/C/116/IAIN/7/G
Updated with Decision(2014)6191 of 26/08/2014
28/08/2014 Centralised - Yearly update (2014)6191 of 26/08/2014
19/01/2015 Centralised - Withdrawal (2015)210 of 15/01/2015